Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-22

Clinical Trial Update: Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort [NA]

View source ↗

Summary

A prospective interventional national cohort study in France to characterize gastroenteropancreatic neuroendocrine tumors treated with targeted radionuclide the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Gastroenteropancreatic Neuroendocrine Tumor, Radiotherapy | NA | Status: RECRUITING